# Vanda Pharmaceuticals Inc.: Form 8-K, filed May 20, 2024

- Company: [Vanda Pharmaceuticals Inc.](/companies/vnda.md) (CIK 1347178)
- Form: 8-K
- Filed: 2024-05-20
- Accepted by EDGAR: May 20, 2024, 17:26 ET
- Period: 2024-05-17
- Accession: 0001628280-24-024405
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1347178/000162828024024405/vnda-20240517.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1347178/000162828024024405/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1347178/000162828024024405/vnda-20240517.htm

Filed May 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-024405. Last ingested by Listed: Oct 29, 2026, 08:08 ET. No prices; not investment advice.